Printed from https://ideas.repec.org/s/spr/eujhec.html
Content
August 2026, Volume 27, Issue 6
- 1149-1169 Assessing the economic burden of complicated urinary tract infection: A systematic literature review
by Edward Broughton & Ann Colosia & Meryem Bektas & Kristi Kuper & Ramy Kotb - 1171-1190 Broadening sources of finance for health promotion and disease prevention: Smart capacitating investment
by Maureen Rutten-van Mölken & Holly Whiteley & Balázs Babarczy & Jacob Davies & Lucas Goossens & Lina Papartyte & Alison Maassen & Balázs Nagy & Stephen Wright & Rhiannon Tudor-Edwards & the Invest4Health Consortium - 1191-1212 How tax structures for retail cannabis shape cannabis use among youth and young adults: evidence from a volumetric choice experiment
by Lei Xu & Yanyun He & Hojin Park & Shiqi Zhang & Shaoying Ma & Ce Shang - 1213-1231 Health expenditure in Africa: examining the synergistic impact of economic policy uncertainty and governance quality
by Ekene ThankGod Emeka & Simplice Asongu - 1233-1249 Parental risk preferences and children’s vaccination coverage
by Flavia Coda Moscarola & Sarah Zaccagni - 1251-1259 Productivity costs associated with premature deaths due to acute myocardial infarction in Spain: analysis from 2013 to 2022
by Josep Darbà & Meritxell Ascanio & Antonio Rodríguez - 1277-1291 Bridging success in the labour market: does continuity of general practitioners’ care matter for individuals with common mental disorders?
by M. Kamrul Islam & Håvard Thorsen Rydland & Egil Kjerstad - 1293-1322 Life-cycle health effects of compulsory schooling
by Johannes Hollenbach & Hendrik Schmitz & Beatrice Baaba Tawiah - 1323-1349 The effect of age-specific stay-at-home recommendation on healthcare utilization: Evidence from Finland’s COVID-19 policy
by Jukka Laaksonen & Mika Kortelainen & Henri Salokangas - 1351-1357 Revisiting health state preferences after 20 years: A new EQ-5D-3L value set for the Netherlands
by Bram Roudijk & Marcel F. Jonker - 1359-1378 Assessing the costs and benefits of non-pharmaceutical pandemic measures using the economic values of social contacts
by Mortaza Baky Haskuee & Ali Asgary & Zachary McCarthy & Sperydon Koumarianos & Callista Wu & Ali Parsa & Andrew Fallone & Jianhong Wu
July 2026, Volume 27, Issue 5
- 945-956 The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS
by Matthew Walton & Nyanar Jasmine Deng & Mark Corbett & Chinyereugo Umemneku-Chikere & Sarah Nevitt & Helen Fulbright & Chong Yew Tan & Robin Lachmann & Rachel Churchill & Robert Hodgson - 957-967 Economic burden of eosinophilic esophagitis in the first year after diagnosis in Spain: A direct medical cost analysis
by Leticia Rodriguez-Alcolado & Isaac Aranda-Reneo & Sergio Casabona & Isabel Pérez-Martínez & Danila Guagnozzi & Carolina Gutiérrez-Junquera & Edurne Amorena & Antonio Guardiola-Arévalo & Luisa de la Peña-Negro & Leonardo Blas Jhon & Sandra López García-Dionisio & Jennifer Fernández-Pacheco & Jesús Barrio & Sonia Fernández-Fernández & Elena Betoré & Susana de la Riva & Carlos Teruel Sánchez-Vegazo & Juan Armando Rodríguez-Oballe & Juan Enrique Naves & Juan K. Bisso-Zein & Silvia Carrión & Adolfo Suárez & Ronald Llerena-Castro & Alejandro García-Díaz & Óscar Nantes-Castillejo & Alicia Granja-Navacerrada & Antonia Perelló & Marta Álvarez-García & Cecilio Santander & Emilio J. Laserna-Mendieta & Juan Oliva-Moreno & Alfredo J. Lucendo - 969-985 Estimating the magnitude and scope of disability-related direct costs: a systematised review
by Lena Morgon Banks & Zachary Morris & Sara Rotenberg & Daniel Mont & Monica Pinilla-Roncancio & Ludovico Carraro & Alex Cote & Mercoledi Nasiir & Jill Hanass-Hancock & Stephen McGarity & Pamela Smith & Sophie Mitra - 987-1002 Demographic and health impacts of women’s bodily autonomy: switching prescription requirements for emergency contraceptives
by Fabian Grünwald & Tom Stargardt - 1003-1026 Ex ante evaluation of risk adjustment models for prospective provider payment: a conceptual framework and empirical application
by Andreea Panturu & Richard van Kleef & Frank Eijkenaar - 1027-1046 Healthcare costs of foodborne diseases in the United States: an analysis using electronic health records
by Xuerui Yang & James A. Barkley & Barbara B. Kowalcyk & Robert L. Scharff - 1047-1059 Willingness to pay for a quality adjusted life year across different time horizons: direct elicitation in Quebec
by Hosein Ameri & Dan Alexandru Danita & Thomas G. Poder - 1061-1072 Cost-utility of focused ultrasound compared to radiotherapy for Dutch patients with uncomplicated non-spinal bone metastases
by Julia Simões Corrêa Galendi & Ingrid Nijholt & Renée Hovenier & Jorik Slotman & Erik Phernambucq & Stephanie Stock & Clemens Bos & Manon Braat & Helena Verkooijen & Martijn Boomsma & Dirk Müller - 1073-1085 A cross-country comparison of the psychometric performance of SF-6Dv2 and EQ-5D-5L
by Hosein Ameri & Brendan Mulhern & Richard Norman & Takeru Shiroiwa & Rajabali Daroudi & Thomas G. Poder - 1087-1102 The disability and care squeeze: the effects of children’s disability and special healthcare needs on parents’ employment in Australia
by Benojir Ahammed & Khorshed Alam & Zahirul Hoque & Syed Afroz Keramat - 1103-1115 Cost-effectiveness of testing biofluid biomarkers to diagnose Alzheimer’s disease: a systematic review
by Hanzi Jiang & Sergio Escamilla & Molly Beestrum & Federico Salas-Lucia - 1117-1148 Patient and medical choice across public and private health providers: the case of birth timing manipulation in Brazil
by Paula Spinola & Rudi Rocha
June 2026, Volume 27, Issue 4
- 779-780 Message from the New Editor-in-Chief
by Arndt Reichert - 781-790 Are there differences in health state preferences between urban and rural respondents? a comparison using time trade-off and discrete choice experiment
by Shitong Xie & Jing Wu & Feng Xie - 791-800 Far more than a shot in the arm: Vaccines and consumer spending
by Serhan Cevik - 801-819 Educational gradient in physiological risk factors in a workplace: a decomposition analysis of biomarkers
by Toshiaki Aizawa - 821-842 Economic burden and cost drivers of interstitial lung disease: a systematic review
by Siow Yeh Chiew & Mustapha Mohammed & Siew Chin Ong - 843-855 Quality of life utility-Core 10 dimensions (QLU-C10D) scores based on cancer patients’ health preferences are more sensitive than those based on general public’s health preferences
by Yiyin Cao & Haofei Li & Xu Jin & Madeleine T. King & Richard Norman & Ling Jie Cheng & Hongjuan Yu & Weidong Huang & Nan Luo - 857-868 Mapping of the EORTC QLQ-LC43 to EQ-5D-5 L index in patients with lung cancer: comparison of traditional regression models with machine learning technique
by Longlin Jiang & Yan Miao & Hong Zhou & Lin Peng & Yongtao Han & Xi Luo & Qiuling Shi & Xuefeng Leng & Qing Yang - 869-879 Long-term effectiveness and cost-effectiveness of testing for alemtuzumab antidrug antibodies to guide treatment in multiple sclerosis: a modelling study
by Timothy Jamieson & Florian Tomini & Sharmilee Gnanapavan & Borislava Mihaylova - 881-891 Change in healthcare resource use and associated costs of patients with metastatic lung cancer between 2013 and 2021: an observational study from the French national health data system
by Christos Chouaid & Clarisse Marchal & Marion Apert & Lionel Bensimon & Valérie Guimard & Mélanie Née & Manon Belhassen & Gérard de Pouvourville & Jean-Yves Blay - 893-903 Eliciting discounting model and direction at the individual level with time trade-off follow-up questions
by Michał Jakubczyk - 905-914 Is next generation sequencing for the diagnosis of rare diseases worth its cost? A user-based approach to valuation
by Karen V. MacDonald & Sebastian Heidenreich & Nicolas Krucien & Kym M. Boycott & Francois P. Bernier & Mandy Ryan & Deborah A. Marshall - 915-927 Cost analysis of transthyretin amyloid cardiomyopathy in heart failure patients with preserved ejection fraction in Spain
by Pablo García-Pavía & José Manuel García-Pinilla & Javier Rejas-Gutierrez & Laura Bernal & Patricia Tarilonte & Carmen Peral - 929-944 Multinational stakeholder engagement to inform future development and refinement of the EuroQol toddler and infant populations (EQ-TIPS)
by J. Verstraete & S. Schieskow & J. Jelsma & M. Herdman & B. M. Morrow & K. Dalziel & E. Bidgood
April 2026, Volume 27, Issue 3
- 509-526 Labor market entry prospects of people with visual impairments: evidence from administrative register data in the Netherlands
by Katharina Diehl & Eline Heppe & Melvin Vooren & Ilja Cornelisz & Chris van Klaveren - 527-540 Estimating QALYs in adults with cerebral palsy: mapping the San Martin scale to the EQ-5D-5L for economic evaluation
by Diana Marcela Nova Díaz & Aritz Adin & Eduardo Sánchez-Iriso - 541-552 Cost-utility analysis of a web-based interactive patient education platform: evidence from a randomized clinical trial for end-stage renal disease patients
by Modou Diop & Lionel Perrier & Baptiste Haon & Lise Rochaix & Luc Behaghel & Jean-Claude K. Dupont & Magali Morelle & Michelle Elias & Laure Esposito & Christophe Legendre & Hélène Longuet & Isabelle Durand-Zaleski & Evangéline Pillebout - 553-569 Does chronic disease coverage for outpatient care affect healthcare utilization and expenditures in China? Evidence from an administrative claim dataset
by Wen He & Yanyao Li - 571-580 Total costs of different lines of treatment in diffuse large B-cell lymphoma in Denmark – a real-world data analysis
by Christian Graves Beck & Martin Lucas Jørgensen & Maya Friis Kjaergaard & Søren Ramme Bro & Tove Holm-Larsen - 581-590 Pembrolizumab vs. chemotherapy in the first-line setting of PD-L1 ≥ 50% metastatic non-small cell lung cancer: a real-world cost-effectiveness analysis
by Brandon Liu & Ambica Parmar & Jin Luo & Wei Fang Dai & Kelvin K. W. Chan - 591-607 Does access to quality accreditation improve health? - Patient-level evidence from German cancer care
by Tim Brand & Katharina Blankart - 609-622 United Kingdom value set for the functional assessment of cancer therapy eight dimension (FACT-8D) preference-based quality of life instrument
by R. Norman & R. Campbell & D. Rowen & R. Viney & D. J. Street & F. Müller & R. Mercieca-Bebber & A. S. Pickard & D. Cella & J. W. Shaw & M. T. King - 623-636 Does opt-out legislation crowd out living organ donations? A cross-country study
by Stefan Felder & Richard Abbasi - 637-649 Informing decisions in light of parameter uncertainty – an economic evaluation of the adjuvanted recombinant herpes zoster vaccine in Sweden
by Camilla Nystrand & Katarina Widgren & Shuang Hao & Emelie Heintz & Vibeke Sparring - 651-661 TF-TAVI and SAVR post-procedural complications in Germany 2021/2022 – impact on healthcare resource consumption
by Alexander Maier & Alicja Zientara & Markus Jäckel & Jonathan Rilinger & Christian Weber & Vera Oettinger & Lukas A. Heger & Derek Hazard & Roman Gottardi & Martin Czerny & Dirk Westermann & Constantin von zur Mühlen & Klaus Kaier - 663-673 Trends in the economic burden of mental disorders over twelve years: the Netherlands mental health survey and incidence study
by S.J. Korteling & M. ten Have & F.W. Thielen & S. van Dorsselaer & M. Tuithof & A.I. Luik & B.F.M. Wijnen - 675-689 Comparing the measurement properties of the EQ-5D-Y-3L and EQ-5D-3L in a general population sample of adults
by Anna Nikl & Valentin Brodszky & Ákos Szabó & Fanni Rencz - 691-698 Costs of productivity loss up to two years after ischaemic stroke
by Ilse Huijberts & Robert J. van Oostenbrugge & Wim H. van Zwam & Alida A. Postma & Florentina M.E. Pinckaers - 699-714 Predicting brand share after LOE in chronic disease market using machine learning
by Seho Park & Kahyun Lee - 715-729 Do EQ-5D-Y-3L value sets have common properties, and how do they compare to EQ-5D-5L value sets?
by Bram Roudijk & Tianxin Pan & Jan Abel Olsen & Nancy Devlin - 731-755 Breaking the habit: a systematic review of the cost-effectiveness of non-pharmacological and combined interventions for smoking cessation in Europe
by Alexander Braun & Walter Hyll & Eva Krczal - 757-768 Variation in patient-reported outcomes after total hip replacement across ten high-volume hospitals in Germany: results from a multicenter, prospective, longitudinal Cohort Study
by Martin Emmert & Cornelia Frömke & Cordula Drach & Laura Heppe & Susann Kiss & Christiane Patzelt & Anja Schindler & Oliver Schöffski & Jona Stahmeyer & Julia Weber & Uwe Sander - 769-778 Child- versus adult-perspective composite time trade-off valuations for the EQ-5D-Y-3L: evidence from the Hungarian valuation study
by Stevanus Pangestu & Bram Roudijk & Fanni Rencz & Stefan A. Lipman
March 2026, Volume 27, Issue 2
- 175-211 Measuring hospital care resilience: a systematic literature review
by Marina Cavalieri & Stefania Fontana & Calogero Guccio & Domenico Lisi & Marco Ferdinando Martorana & Giacomo Pignataro & Domenica Romeo - 213-219 Nexus among health expenditures, ICTs and sustainable economic growth: Insights from South Asian Nationals health and economic issues
by Linmin Chen & Aysha Zamir & Malik Shahzad Shabbir & Andrei Octavian Paraschivescu & Violeta Hazaparu & Florin Radu & Mohammad Jaradat & Iancu Dorin & Gabriela Fotache & Raul Adrian Lile & Ramona Lile & Rusu Corina-Maria & Bondac Georgiana Tatiana - 221-233 Valuing health states for infants and toddlers: challenges and methodological considerations in EQ-TIPS preference elicitation
by Nancy Devlin & Bram Roudijk & Michael Herdman & Elly Stolk & Richard Norman & Simone Kreimeier & Janine Verstraete - 235-244 Willingness to pay for measures to increase use of active school transport
by Kristina Ek & Anna-Karin Lindqvist & Ellen Gustavsson Niemi & Stina Rutberg & Nadja Sirviö - 245-258 Health-related quality of life in patients with alcohol use disorder: comparing instruments and mapping from clinical measures to preference-based measures
by Eva Rodríguez-Míguez & Jacinto Mosquera - 259-276 The value of health and well-being from a societal perspective: A willingness to pay experiment in the Netherlands
by Karen Trujillo Jara & Daphne C. Voormolen & Werner Brouwer & Job van Exel - 277-287 Cost-effectiveness analysis of the covered endovascular reconstruction of the aortic bifurcation versus kissing stents and open surgical repair for the treatment of aorto-iliac occlusive disease
by Xavier G. L. V. Pouwels & Suzanne Holewijn & Daphne van der Veen & Mauricio Gonzalez-Urquijo & Michel M. P. J. Reijnen & Hendrik Koffijberg - 289-304 Comparison of the psychometric performance of experimental EuroQol Toddler and Infant Populations Instrument (EQ-TIPS) and Pediatric Quality of Life Inventory™ (PedsQL) in young children
by Tianxin Pan & Li Huang & Vicky He & Janine Verstraete & Nancy Devlin & Mike Herdman & Kim Dalziel - 305-318 Unravelling heterogeneity in efficiency measurements: a case study of public hospitals in Spain
by Marta Arbelo-Pérez & Violeta De Vera & Antonio Arbelo - 319-337 Exploration of using constrained regression in Germany’s morbidity-based risk adjustment
by Florian Renker & Dennis Häckl & Amelie Wuppermann - 339-353 Valuing health and wellbeing using discrete choice experiment: exploring feasibility, design effect and international preference similarity
by Haode Wang & Donna L. Rowen & Yuen Chen & Clara Mukuria & Deborah Street & Richard Norman - 355-362 Nothing about us, without us? A reflection on and call for involving children in the process of valuing child health
by Ava Hoogenboom & Vivian Reckers-Droog & Stefan Lipman & Werner Brouwer - 363-372 Economic evaluation of advanced practice physiotherapy models of care for upper extremity musculoskeletal disorders In Denmark: a registry-based cohort study
by Simon Lafrance & Cecilie Rud Budtz & Martin Byskov Kinnerup & François Desmeules & Jason Robert Guertin & Merete Nørgaard Madsen & David Høyrup Christiansen - 373-390 Hesitancy and compulsory vaccination: are non-mandatory vaccines the victims? A study on Italian regions
by Luisa Loiacono & Riccardo Puglisi & Leonzio Rizzo & Riccardo Secomandi - 391-410 PROM-based monitoring and alerts reduce post-surgery healthcare utilization of patients undergoing joint replacement: A secondary analysis of the PROMoting Quality RCT
by David Ehlig & Lukas Schöner & Alexander Geissler & Laura Wittich & Reinhard Busse & Justus Vogel - 411-421 Comparing EQ-5D-5L and SF-6Dv2 utilities with QLU-C10D utilities in hematologic cancer patients
by Tiantian Zhang & Aixue Zhang & Jing Li & Fangyu Li & Peng Liu & Pei Wang - 423-433 Healthcare costs associated with gender dysphoria in children, adolescents and young adults in germany: A prevalence-based analysis using statutory health insurance data
by Sophie Gottschalk & Claudia Konnopka & Katja Nettermann & Alicia Başoğlu & Ursula Marschall & Dirk Horenkamp-Sonntag & Angela Rölver & André Karch & Georg Romer & Hans-Helmut König - 435-451 Translating the EORTC CAT core and the QLQ-C30 to the EQ-5D-5L in patients with metastatic breast cancer: A comparison of direct and indirect mapping algorithms
by Pimrapat Gebert & Anna Maria Hage & Felix Fischer & Christoph Paul Klapproth & Ulrike Grittner & Maria Margarete Karsten - 453-477 Tough versus soft regulations to promote generic medications in Italy
by Aarushi Dhingra & Gianluca Fiorentini & Ayman Fouda & Naomi Moy - 479-508 Price determinants and pricing policies concerning potentially innovative health technologies: a scoping review
by Nicolas S. H. Xander & Tom Belleman & Maximilian Salcher-Konrad & Anne Hendrickx & Jeffrey Chen & Anne-Sophie Klein Gebbink & Peter Schneider & Kate Morgan & Oliver Groene & Isabelle Durand-Zaleski & Frederick W. Thielen & Carin A. Uyl-de Groot
February 2026, Volume 27, Issue 1
- 1-15 Long-term costs associated with healthcare use of people with cancer in Scotland
by Kenny Haining & Elizabeth Lemmon & Peter Hall & Nazir I. Lone - 17-28 Predicting EQ-5D-3L utility values from clinical data in a prospective cohort of kidney transplant recipients
by V. Bonnemains & Y. Foucher & P. Tessier & C. David & M. Giral & E. Dantan - 29-45 Clinical equivalence and non-inferiority within health technology assessment
by Matthew Taylor & Joe Goldbacher & Charlotte Graham & James Mahon & Mike Chambers - 47-63 Time preferences and COVID-19 vaccination uptake
by Arthur E. Attema & Marcello Antonini & Mesfin Genie & Aleksandra Torbica & Francesco Paolucci - 65-76 Cost-effectiveness of Mavacamten for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy using a French healthcare perspective
by Francois-Emery Cotté & Michael Hurst & Sarah Akarkoub & Melissa Ho & Julien Vernon & Lou Chambry & Sandy Leproust - 77-94 Cost-effectiveness of treatments for presymptomatic newborn patients with spinal muscular atrophy and two or three copies of the survival motor neuron 2 gene in Italy
by Ilaria Valentini & Gianni Ghetti & Marika Pane & Filippo Rumi & Eugenio Di Brino & Michele Basile & Gabriele Maria Pistillo & Matthias Bischof - 95-116 Trends in physical and mental health needs across generations in Australia
by Sabrina Lenzen & Luke Connelly & William Whittaker & Stephen Birch - 117-133 A model-based cost-effectiveness analysis of prescribing by dietitians and therapeutic radiographers in England
by Saeideh Babashahi & Nicola Carey & Karen Stenner & Kath Hart & Yogini Jani & Judith Edwards & Natalia Hounsome - 135-147 Pharmacy cost groups for the German morbidity-based risk compensation scheme
by Christian J. A. Schindler & Benjamin Berndt & Dennis Häckl - 149-166 Health economic outcomes and national economic impacts associated with Long COVID in England and Scotland
by Joseph Kwon & Joseph Mensah & Ruairidh Milne & Clare Rayner & Román Rocha Lawrence & Johannes De Kock & Manoj Sivan & Stavros Petrou - 167-169 Critical issues with methods and results interpretation at validating the EQ-5D-5L and QLU-C10D utilities in gastric cancer patients
by Simone Seyringer & Eva Maria Gamper - 171-172 Do we need a health technology assessment approach for non-inferiority specifically? A comment on: clinical equivalence and non-inferiority within health technology assessment by Taylor et al. (2025)
by Beryl Primrose Gladstone & Werner Vach - 173-174 Cost-of-illness of myelodysplastic syndromes in Italy. A reply to Tse et al
by Carlo Lazzaro
December 2025, Volume 26, Issue 9
- 1525-1537 Economic evaluation on dental caries preventive interventions for Australian children using a priority-setting approach
by Tan Minh Nguyen & Long Khanh-Dao Le & Hanny Calache & Cathrine Mihalopoulos - 1539-1555 Personnel shortages and the provision of long-term care: an empirical analysis of German nursing homes
by Dörte Heger & Annika Herr & Maximilian Lückemann & Arndt Reichert & Leonie Tycher - 1557-1567 Economics of hypothalamic obesity in patients with craniopharyngioma and other rare sellar/suprasellar tumors
by Julian Witte & Nicolas Touchot & Bastian Surmann & Kylie Braegelmann & Mathias Flume & Julia Beckhaus & Carsten Friedrich & Hermann L. Müller - 1569-1579 Challenges and reforms in Spain’s health technology assessment system: analysis of criteria influencing medicines’ reimbursement decisions between 2019 and 2022 in Spain
by Pilar Pinilla-Dominguez & Jaime Pinilla-Dominguez - 1581-1595 Uncovering the health divide: examining the influence of poverty risk and income inequality on health outcomes in over 300 Finnish municipalities
by Saqib Amin - 1597-1611 Investment gaps in antimicrobial resistance research & development: trends in Europe, 2017–2021
by Elisa Fabbro & Usha Lamichhane & Ralf Sudbrak & Lesley Ogilvie & Antonio Vitiello & Andrea Zovi & Michela Sabbatucci - 1613-1631 How perceptions of bone marrow donation costs affect donation behavior: survey evidence from a large donor registry
by Michael Haylock & Patrick Kampkötter & Mario Macis & Susanne Seitz & Robert Slonim & Edith Wienand & Daniel Wiesen & Alexander H. Schmidt - 1633-1643 Cost-effectiveness of dialectical behavioural therapy versus treatment as usual for autism with suicidal behaviours: single-blind randomised controlled trial
by Anne Huntjens & Filip Smit & L. M. C. Bosch & Ad Kerkhof & Bram Sizoo & Mark Gaag - 1645-1654 One week versus three to five weeks of plaster cast immobilization for nonreduced distal radius fractures, a cost effectiveness analysis embedded in a stepped wedge cluster randomized controlled trial
by Marcel A. N. Bruijn & Emily Z. Boersma & Lysanne Silfhout & Tjarda N. Tromp & Eddy M. M. Adang & Erik Krol & Michael J. R. Edwards & Vincent M. A. Stirler & Erik Hermans - 1655-1670 Economic evaluations of early detection strategies for pancreatic cancer: a systematic review
by Robert Wittram & Léon Kreis & Hans-Helmut König & Christian Brettschneider - 1671-1682 Psychometric comparison of CHU9D and PedsQL 4.0 proxy version administered to parents of children with congenital colorectal conditions in Australia
by Tianxin Pan & Misel Trajanovska & Nathan Kwong & Sebastian K. King & Ilias Goranitis - 1683-1704 Is episodic future thinking effective in mitigating the influence of time preference in time trade-off?
by Zhongyu Lang & Liying Zhang & Stefan A. Lipman & Bradley Sugden & Kim Rand & Arthur E. Attema - 1705-1705 Replay to: Comparison of EQ-5D-5 L and EORTC QLU-C10D utilities in gastric cancer patients
by Wang Pei - 1707-1707 Correction: Is episodic future thinking effective in mitigating the influence of time preference in time trade-off?
by Zhongyu Lang & Liying Zhang & Stefan A. Lipman & Bradley Sugden & Kim Rand & Arthur E. Attema
November 2025, Volume 26, Issue 8
- 1293-1332 Health shocks and health behavior: a long-term perspective
by Christian Bünnings & Irina Simankova & Harald Tauchmann - 1333-1345 The role of budget impact in reimbursement decisions in The Netherlands: interviews with decision-makers and pharmaceutical industry representatives
by Vivian Reckers-Droog & Joost Enzing & Werner Brouwer - 1347-1368 Comparing the measurement properties of the EQ-5D-Y-3L, EQ-5D-Y-5L and CHU9D in children and adolescents: a measurement property study
by Caique de Melo do Espirito Santo & Verônica Souza Santos & Yasmin Brasileiro de Souza & Aureliano Paolo Finch & Janine Verstraete & Gisela Cristiane Miyamoto & Tiê P. Yamato - 1369-1381 Loss aversion in EQ-5D-Y-3L: does it explain differences in willingness to trade-off life years in adults and children?
by Ava F. H. Hoogenboom & Stefan A. Lipman - 1383-1399 A systematic review of minimum important changes for generic multi-attribute utility instruments and recommendations for their estimation
by Glen J. Henson & Ingrid Mei & Bruce V. Taylor & Paul Scuffham & Gang Chen & Julie A. Campbell - 1401-1413 Does timing matter? The role of health information shocks in measuring willingness to pay
by Carolin Brinkmann & Sebastian Neumann-Böhme & Werner B. F. Brouwer & Tom Stargardt - 1415-1438 Deterioration of health-related quality of life: the hidden health burden of informal caregiving
by Syed Afroz Keramat & Prianka Maria Sarker & Tracy Comans & Deborah Brooks & Nadeeka N. Dissanayaka - 1439-1457 How a nation’s well-being influences its health profile: an analysis of critical indicators
by Iulia Cristina Iuga & Raluca Andreea Nerişanu & Horia Iuga - 1459-1467 The effect of displaying laboratory test prices on physicians’ ordering behaviour: a systematic review of European studies
by Katrine Villaume Roedbro & Signe Smith Jervelund - 1469-1485 Burden of myelodysplastic syndromes: a systematic literature review of economic burden
by Preston Tse & Shitong Xie & Jiajun Yan & Brittany Humphries & Feng Xie - 1487-1502 Compliance with clinical guidelines: the role of incentives and competition between practitioners
by Gianluca Fiorentini & Luke B. Connelly - 1503-1524 Psychological distress and productivity loss: a longitudinal analysis of Australian working adults
by Syed Afroz Keramat & Tracy Comans & Alison Pearce & Rabeya Basri & Rubayyat Hashmi & Nadeeka N. Dissanayaka
September 2025, Volume 26, Issue 7
- 1127-1136 Routine measurement in low back pain; towards a pragmatic patient-reported productivity cost outcome measurement using the institute for medical technology assessment productivity cost questionnaire
by Adekunle Z. Ademiluyi & Antoinette D. I. Asselt & Michiel F. Reneman - 1137-1147 Price transparency in the Dutch market-based health care system: did price dispersion for similar hospital services reduce over time?
by Frédérique Franken & Rudy Douven & Stéphanie Geest & Marco Varkevisser - 1149-1162 The health and long-term care costs in the last year of life in The Netherlands
by Christel E. Dijk & Tristan Langereis & Jan-Willem H. Dik & Trynke Hoekstra & Bernard Berg - 1163-1173 Public versus private healthcare systems in the OECD area– a broad evaluation of performance
by Per Molander - 1175-1190 Test-retest reliability of the Online Elicitation of Personal Utility Functions (OPUF) approach for valuing the EQ-HWB-S
by Aisha Moolla & Paul Schneider & Ole Marten & Clara Mukuria & Tessa Peasgood - 1191-1208 Changes in spending, quality indicators, and provider experiences following the introduction of a population-based payment model in dutch primary care: a mixed methods evaluation
by Tadjo Gigengack & Daniëlle Cattel & Frank Eijkenaar - 1209-1218 The impact of parastomal hernia on quality of life using data from the CIPHER prospective cohort study
by Joel Glynn & William Hollingworth & Jessica Harris & Syed Mohiuddin & Lucy Ellis & Barnaby C. Reeves & Neil Smart - 1219-1232 Association of medication adherence with treatment preferences: incentivizing truthful self-reporting
by Carina Oedingen & Raf Gestel & Samare P. I. Huls & Georg Granic & Esther W. Bekker-Grob & Jorien Veldwijk - 1233-1247 Psychometric benefits of adding bolt-ons to the EQ-5D-5L in populations undergoing minimally invasive cosmetic procedures
by Eszter Mercédesz Müller & Anna Nikl & Máté Krebs & Péter Holló & Valentin Brodszky & Lajos Vince Kemény & Fanni Rencz - 1249-1262 Characterizing a heterogeneous chronic patient population for redesigning person-centred bundled payment models using risk-mitigating measures
by Sterre S. Bour & Lucas M. A. Goossens & Maureen P. M. H. Rutten-van Mölken - 1263-1273 Health state utilities associated with X-linked retinitis pigmentosa (XLRP)
by Louis S. Matza & Nan Li & Katie D. Stewart & Mahmoud Hashim & Tom Denee & Feng Pan & Qiaoyi Zhang & Jennifer Lee & Michel Michaelides & Hendrik P. N. Scholl - 1275-1291 Preferences for health-related quality of life: do they vary by age? A systematic literature review on the EQ-5D measure
by Alhanouf Alabbad & Madeleine Cochrane & Paul Mark Mitchell
August 2025, Volume 26, Issue 6
- 877-892 Healthcare expenditures and economic growth: evidence via panel local projections
by William Ginn - 893-926 Economic and human burden attributable to antimicrobial resistance in Spain: a holistic macro-estimation of costs
by Sabela Siaba & Bruno Casal - 927-943 Patient-level cost analysis of subfertility pathways in the Dutch healthcare system
by Maura Leusder & Hilco J. Elten & Kees Ahaus & Carina G. J. M. Hilders & Evert J. P. Santbrink - 945-968 How are patient inputs considered in HTA? A thematic document analysis of NICE ultra-rare disease appraisals
by Arianna Gentilini & Alina Rana - 969-985 The ACA Medicaid expansions and abortion rates among young adults
by Masanori Kuroki - 987-1022 Exploring the influence of medical staffing and birth volume on observed-to-expected cesarean deliveries: a panel data analysis of integrated obstetric and gynecological departments in Germany
by Arno Stöcker & Holger Pfaff & Nadine Scholten & Ludwig Kuntz - 1023-1039 Medical teleconsultation from the patient’s perspective. A demographic segmentation
by Jorge Arenas-Gaitán & Patricio E. Ramírez-Correa & Pablo Ledesma-Chaves & Luis J. Callarisa Fiol - 1041-1067 Explaining variations in government health expenditure: evidence from Canada
by Livio Di Matteo & Fraser Summerfield - 1069-1077 Changes in disposable income of Polish households and growing trends in alcohol mortality
by Jacek Moskalewicz & Jakub Stokwiszewski & Łukasz Wieczorek & Bogdan Wojtyniak - 1079-1099 Age, morbidity, and time to death: End-of-life expenditures on health care for the young-old population
by Irene Torrini & Claudio Lucifora & Antonio Giampiero Russo - 1101-1110 Cost comparison analysis of onasemnogene abeparvovec and nusinersen for treatment of patients with spinal muscular atrophy type 1 in the Netherlands
by Simon Schans & Rimma Velikanova & Diana Weidlich & Ruth Howells & Anish Patel & Matthias Bischof & Maarten J. Postma & Cornelis Boersma - 1111-1126 Population norms for the EQ-5D-5L for Hungary: comparison of online surveys and computer assisted personal interviews
by Márta Péntek & Viktor Jáger & Áron Kincses & Áron Hölgyesi & Zsombor Zrubka & Petra Baji & Levente Kovács & László Gulácsi
July 2025, Volume 26, Issue 5
- 697-710 Cost-effectiveness and cost-utility analysis of a nurse-led, transitional care model to improve care coordination for patients with cardiovascular diseases: results from the “Cardiolotse” study
by Marie Coors & Wiebke Schüttig & Katrin C. Reber & Harald Darius & Alfred Holzgreve & Sebastian Karmann & Anica Stürtz & Rebecca Zöller & Saskia Kropp & Petra Riesner & Leonie Sundmacher - 711-719 The economic costs and consequences of (insufficient) sleep: a case study from Latin America
by María Victoria Anauati & Matías Gómez Seeber & Sebastián Campanario & Walter Sosa Escudero & Diego A. Golombek - 721-733 Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma
by Simone Seyringer & Micha J. Pilz & Andrew Bottomley & Madeleine T. King & Richard Norman & Eva M. Gamper - 735-744 Cost-utility of cochlear implantation in single-sided deafness and asymmetric hearing loss: results of a randomized controlled trial
by Mathieu Marx & Michaël Mounié & Isabelle Mosnier & Frédéric Venail & Michel Mondain & Alain Uziel & David Bakhos & Emmanuel Lescanne & Yann N’Guyen & Daniele Bernardeschi & Olivier Sterkers & Benoit Godey & Gwenaëlle Creff & Sébastien Schmerber & Nicolas-Xavier Bonne & Christophe Vincent & Bernard Fraysse & Olivier Deguine & Nadège Costa - 745-755 Cost-effectiveness of TAVI in the United Kingdom: a long-term analysis based on 4-year data from the Evolut Low Risk Trial
by Daniel J. Blackman & Anne M. Ryschon & Sophie Barnett & Abigail M. Garner & John K. Forrest & Michael R. Reardon & Jan B. Pietzsch - 757-776 Regional variation in the utilization of nursing home care in Germany
by Annika Herr & Maximilian Lückemann & Amela Saric-Babin - 777-795 Exploring the social value and design preferences for a home-based dementia community program in Australia
by Sabrina Lenzen & Brenda Gannon & Richard Norman & Sally Bennett & Lindy Clemson & Laura Gitlin - 797-816 Expensive today but cheaper tomorrow: lifetime costs of an active middle ear implant compared to alternative treatment options
by Markus Krohn & Klaas Kiesewetter & Annika Buchholz & Bettina Schlick & Susan Busch & Thomas Lenarz & Anke Lesinski-Schiedat & Hannes Maier & Cornelia Batsoulis & Michael Urban & Steffen Flessa - 817-837 The effect of workload on primary care doctors on referral rates and prescription patterns: evidence from English NHS
by Hanifa Pilvar & Toby Watt - 839-853 Can wage changes solve the labour crisis in the National Health Service?
by Xingzuo Zhou & Jolene Skordis & Junjian Yi & Yiang Li & Jonathan Clarke & Hongkun Zhang - 855-868 Interprofessional team-based primary care practice and preventive cancer screening: evidence from Family Health Teams in Ontario, Canada
by Yihong Bai & Jennifer Reid & Steven Habbous & Rose Anne Devlin & Liisa Jaakkimainen & Sisira Sarma - 869-876 The economic burden of asthma in Italy: evaluating the potential impact of different treatments in adult patients with severe eosinophilic asthma
by Matteo Scortichini & Francesco Saverio Mennini & Andrea Marcellusi & Martina Paoletti & Carlo Tomino & Paolo Sciattella
June 2025, Volume 26, Issue 4
- 537-540 Pricing combination products: not how but who?
by Adrian Towse & Andrew Briggs & Lotte Steuten - 541-560 Does implementing opt-out solve the organ shortage problem? Evidence from a synthetic control approach
by Selina Schulze Spuentrup - 561-575 Strategic behavior and entry deterrence by branded drug firms: the case of authorized generic drugs
by Lu Yao & Mengde Liu - 577-588 Comparison of the EQ-5D-Y and the CHU-9D instruments in a general child population based on self-reports and proxy-reports
by Yan Li & Yanqiu Chen & Jize Sun & Mingyu Jiang & Aixia Ma & Tiantian Tao & Pingyu Chen - 589-604 Comparison of four approaches in eliciting health state utilities with SF-6Dv2
by Hosein Ameri & Thomas G. Poder - 605-617 The societal cost of ‘unwanted’ loneliness in Spain
by Bruno Casal & Eva Rodríguez-Miguez & Berta Rivera - 619-625 Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain
by Josep Darbà & Meritxell Ascanio & Ainoa Agüera - 627-639 Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases
by Ákos Szabó & Valentin Brodszky & Fanni Rencz - 641-651 Adverse selection and consumer inertia: empirical evidence from the Dutch health insurance market
by Ramsis R. Croes & Frederik T. Schut & Marco Varkevisser - 653-670 Benefits beyond health in the willingness to pay for a quality-adjusted life-year
by Linda M. Vries & Werner B. F. Brouwer & Pieter H. M. Baal - 671-682 Comparing the measurement properties of the EQ-5D-5 L, SF-6Dv2, QLU-C10D and FACT-8D among survivors of classical Hodgkin’s lymphoma
by Richard Huan Xu & Zuyi Zhao & Tianxin Pan & Andrea Monteiro & Hongfei Gu & Dong Dong - 683-696 Drug pricing models, no ‘one-size-fits-all’ approach: a systematic review and critical evaluation of pricing models in an evolving pharmaceutical landscape
by Evert A. Manders & Sibren den Berg & Saco J. Visser & Carla E. M. Hollak
April 2025, Volume 26, Issue 3
- 337-351 Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19
by Wenjing Zhou & Yaqin Li & Jan Busschbach & Michael Herdman & Zhihao Yang & Yanming Lu - 353-361 The formal care costs of dementia: a longitudinal study using Swedish register data
by Jennifer Zilling & Ulf-G. Gerdtham & Johan Jarl & Sanjib Saha & Sofie Persson - 363-375 A critical review of the use of R2 in risk equalization research
by Wynand P. M. M. Ven & Richard C. Kleef - 377-402 Time value of informal care of people with alzheimer’s disease in Spain: a population-based analysis
by Vilaplana-Prieto C & Oliva-Moreno J - 403-411 Testing four cognition bolt-on items to the EQ-5D in a general Chinese population
by Meixia Liao & Hongyan Wu & Zhihao Yang & Yan Huang & Mathieu F. Janssen & Gouke Bonsel & Nan Luo - 413-425 Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens
by Sara W. Quist & Sophie te Dorsthorst & Roel D. Freriks & Maarten J. Postma & Carel B. Hoyng & Freekje Asten - 427-454 Cost effectiveness of a GP delivered medication review to reduce polypharmacy and potentially inappropriate prescribing in older patients with multimorbidity in Irish primary care: the SPPiRE cluster randomised controlled trial
by Paddy Gillespie & Frank Moriarty & Susan M. Smith & Anna Hobbins & Sharon Walsh & Barbara Clyne & Fiona Boland & Tara McEnteggart & Michelle Flood & Emma Wallace & Caroline McCarthy - 455-471 Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade
by Lotte Westerink & Sharon Wolters & Guiling Zhou & Arjan Postma & Cornelis Boersma & Job Frank Martien Boven & Maarten Jacobus Postma - 473-485 The added value of the cognition, dining, gastrointestinal problems, sleep and tiredness bolt-on dimensions to the EQ-5D-5L in patients with coeliac disease
by M. Mercédesz Angyal & Mathieu F. Janssen & Péter L. Lakatos & Valentin Brodszky & Fanni Rencz - 487-501 Valuation of the EQ-5D-3L in Jordan
by Abeer Rabayah & Bram Roudijk & Fredrick Dermawan Purba & Fanni Rencz & Saad Jaddoua & Uwe Siebert - 503-512 Should Scotland provide genome-wide sequencing for the diagnosis of rare developmental disorders? A cost-effectiveness analysis
by Michael Abbott & Mandy Ryan & Rodolfo Hernández & Lynda McKenzie & Sebastian Heidenreich & Lynne Hocking & Caroline Clark & Morad Ansari & David Moore & Anne Lampe & Ruth McGowan & Jonathan Berg & Zosia Miedzybrodzka - 513-536 An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries
by Giovanny Leon & Christophe Carbonel & Aparajit Rampuria & Ravindra Singh Rajpoot & Parth Joshi & Panos Kanavos
March 2025, Volume 26, Issue 2
- 147-151 Setting incentives right with long-term risk adjustment
by Simon Reif & Sabrina Schubert & Achim Wambach - 153-182 Long-term returns to local health-care spending
by Jakub Červený & Jan C. van Ours - 183-198 Monetary value of health—a practical decision-making framework combining equity considerations and WTP
by Elizabeta Ribarić & Ismar Velić & Ana Bobinac - 199-222 Workload and short sickness absences in a cohort of Finnish hospital employees
by Tero Kuusi & Martti Kulvik & Mikko Härmä & Annina Ropponen - 223-231 Population normative data for OxCAP-MH capability scores
by Péter György Balázs & Agata Łaszewska & Judit Simon & Valentin Brodszky - 233-241 Does medial tourism promote growth in healthcare sector?
by Hassan F. Gholipour & Kourosh Esfandiar - 243-265 The hidden cost of sophistication: economic complexity and obesity
by Ronald Djeunankan & Sosson Tadadjeu & Henri Njangang & Ummad Mazhar - 267-273 A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial
by Etienne Minvielle & Henri Leleu & Marc Masseti & Arlindo Ferreira & Gérard Pouvourville & Mario Di Palma & Florian Scotté - 275-297 The EQ-5D-3L valuation study for Bermuda: using an on-line EQ-VT protocol
by Henry Bailey & Bram Roudijk & Ricky Brathwaite - 299-311 Incentivizing adherence to pre-exposure prophylaxis for HIV prevention: a randomized pilot trial among male sex workers in Mexico
by Omar Galárraga & Marta Wilson-Barthes & Carlos Chivardi & Nathalie Gras-Allain & Fernando Alarid-Escudero & Monica Gandhi & Kenneth H. Mayer & Don Operario - 313-323 Migration-related determinants of health-care service utilization among persons with a direct migration background in Germany: an exploratory study based on the German Socio-Economic Panel (SOEP)
by Thomas Grochtdreis & Hans-Helmut König & Judith Dams - 325-335 Economies of scope in the Norwegian public hospital sector
by Nils Arne Lindaas & Kjartan Sarheim Anthun & Sverre A. C. Kittelsen & Jon Magnussen
February 2025, Volume 26, Issue 1
- 1-5 Obesity epidemic in European countries: from an unaddressed risk factor to a medicalized disease?
by Livio Garattini & Giovanni Fattore - 7-21 The performance of the EQ-HWB-S as a measure of quality-of-life of caregivers in families that have experienced adverse events
by Cate Bailey & Kim Dalziel & Leanne Constable & Nancy J. Devlin & Harriet Hiscock & Helen Skouteris & Tessa Peasgood - 23-34 Economic evaluation of intensive home treatment in comparison to care as usual alongside a randomised controlled trial
by Ansam Barakat & Jurgen E. Cornelis & Jack J. M. Dekker & Nick M. Lommerse & Aartjan T. F. Beekman & Matthijs Blankers - 35-48 Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden
by Thomas Sejersen & Sophie Graham & Anne-Berit Ekström & Anna-Karin Kroksmark & Marta Kwiatkowska & Michael L. Ganz & Nahila Justo & Karl Gertow & Alex Simpson - 49-62 Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system
by Silvia Fenix-Caballero & Adrián Sanchez-Vegas & Emilio Jesús Alegre Del-Rey & David Epstein & Leticia Garcia-Mochon & Antonio Olry de Labry Lima - 63-70 Mapping functions for the PHQ-9 and GAD-7 to generate EQ-5D-3L for economic evaluation
by Clara Mukuria & Matthew Franklin & Sebastian Hinde - 71-85 The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries
by Hamraz Mokri & Pieter Baal & Maureen Rutten-van Mölken - 87-93 Is there a link between health care utilisation and subjective well-being? An exploratory study among older Danes
by Maiken Skovrider Aaskoven & Trine Kjær & Dorte Gyrd-Hansen - 95-115 Do institutions matter for citizens’ health status? Empirical evidence from Italy
by M. Alessandra Antonelli & Giorgia Marini - 117-128 Costs associated with insufficient physical activity in Germany: cross-sectional results from the baseline examination of the German national cohort (NAKO)
by Sophie Gottschalk & Hans-Helmut König & Andrea Weber & Michael F. Leitzmann & Michael J. Stein & Annette Peters & Claudia Flexeder & Lilian Krist & Stefan N. Willich & Katharina Nimptsch & Tobias Pischon & Sylvia Gastell & Karen Steindorf & Florian Herbolsheimer & Nina Ebert & Karin B. Michels & Anja Dorrn & Volker Harth & Nadia Obi & André Karch & Henning Teismann & Henry Völzke & Claudia Meinke-Franze & Leon Klimeck & Teresa L. Seum & Judith Dams - 129-139 Cost-effectiveness analysis of procalcitonin and lung ultrasonography guided antibiotic prescriptions in primary care
by Giulio Cisco & Armando N. Meier & Nicolas Senn & Yolanda Mueller & Andreas Kronenberg & Isabella Locatelli & José Knüsli & Loïc Lhopitallier & Noemie Boillat-Blanco & Joachim Marti - 141-142 Letter to the Editor: Lazzaro responds to Kennedy et al
by Carlo Lazzaro - 143-146 Correction: AOTMiT reimbursement recommendations compared to other HTA agencies
by Aneta Mela & Dorota Lis & Elżbieta Rdzanek & Janusz Jaroszyński & Marzena Furtak-Niczyporuk & Bartłomiej Drop & Tomasz Blicharski & Maciej Niewada